PP
PETX

PDT Partners’s Aratana Therapeutics, Inc. PETX Stock Holding History

PDT Partners’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26,800
Closed -$138K – 513
2019
Q2 		$138K Hold
26,800
– – 0.01% 392
2019
Q1 		$96K Sell
26,800
-14,200
-35% -$61.5K 0.01% 415
2018
Q4 		$251K Sell
41,000
-25,218
-38% -$154K 0.01% 383
2018
Q3 		$387K Buy
66,218
+3,489
+6% +$17.4K 0.02% 384
2018
Q2 		$267K Sell
62,729
-56,371
-47% -$284K 0.01% 453
2018
Q1 		$525K Hold
119,100
– – 0.02% 430
2017
Q4 		$626K Sell
119,100
-8,700
-7% -$53.2K 0.02% 406
2017
Q3 		$783K Sell
127,800
-833
-0.6% -$5.27K 0.03% 384
2017
Q2 		$930K Buy
+128,633
New +$791K 0.04% 347
2017
Q1 		– Sell
-41,563
Closed -$298K – 561
2016
Q4 		$298K Sell
41,563
-44,775
-52% -$362K 0.02% 438
2016
Q3 		$808K Hold
86,338
– – 0.05% 325
2016
Q2 		$546K Buy
86,338
+39,800
+86% +$256K 0.04% 321
2016
Q1 		$257K Buy
46,538
+1,200
+3% +$4.51K 0.02% 485
2015
Q4 		$253K Buy
+45,338
New +$300K 0.03% 330
2014
Q4 		– Sell
-40,867
Closed -$410K – 1241
2014
Q3 		$410K Buy
+40,867
New +$495K 0.01% 1000

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

PDT Partners's PETX Position: Q3 2019 in Review

PDT Partners sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 26,800 shares — an estimated $138K sold.

PDT Partners first reported a position in PETX in Q3 2014 and held it in 15 quarters. The position peaked at $930K in Q2 2017. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • PDT Partners reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • PDT Partners sold 26,800 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $138K.
  • PDT Partners first reported a position in Aratana Therapeutics, Inc. in Q3 2014 and held it in 15 quarters.
  • PDT Partners's Aratana Therapeutics, Inc. position peaked at $930K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on PDT Partners's 13F filing for Q3 2019, filed 14 Nov 2019.